P. GREANVILLE—In recent days we have published a number of posts focusing on the central issue that should concern anyone subject to a ruling class that does not represent their interests, or which, more often than not, is criminally inimical to their interests. Fine minds like Garland Nixon and Joti Brar (see here, for example), historian Eric Zuesse, and the Blowback/Billy Bob roundtable —inter alia—have provided great explorations of this topic, but the complexity of the US imperial ruling class makes it hard to pin down. This a historically unusual class due to its many layers of hypocrisy, an enormous machinery of distraction and deception, the diversity and dispersion of its interlocking power centers (conjuring up the “Deep State”), and its sheer overall size.
-
-
BRUCE LERRO—During World War II many European social psychologists fled Europe and contributed some of the best research on group dynamics. This included Asch’s experiment on conformity, and Sherif’s experiments on inter-group conflict. This was followed in the 60s by Moscovici’s study on the power of minorities to influence majorities and Milgram’s great experiment on obedience.
-
INDRAJIT—American propaganda was based on repeating one big lie — that they were the ‘good guys’ — across news, entertainment, and media in general. They repeated that lie so often it felt like truth, but now they’ve lost control of the narrative completely. Whatever’s left of the American reputation is buried under Gaza now.
-
BRUCE LERRO—As famous and respected as he is now, Mead had little influence over the historical development of social psychology because he was a Hegelian and social psychology developed within a Cartesian paradigm. Also, Mead followed Peirce instead of the more individualist James and Dewey as did his fellow sociologists at Chicago.
-
EDITOR—A war on off- patent, FDA-approved, inexpensive, safe “repurposed drugs” has been waged by the pharmaceutical industry for decades in an attempt to preserve profits for novel, patented, high-profit drugs. Ivermectin, a well-known antiviral and anti-parasitic drug (currently a generic, hence its low cost) is at the center of a huge controversy with establishment entities—government agencies, industry groups (Big Pharma), and most media trying to badmouth and criminalise the upstart drug in favor of much more expensive and profitable new drugs patented by Pfizer and similar pharmaceutical oligopolies which may not work as well as Ivermectin.
